Typhoid News and Research

RSS

Scientists warn Americans are expecting too much from a vaccine

The White House and many Americans have pinned their hopes for defeating the COVID-19 pandemic on a vaccine being developed at "warp speed." But some scientific experts warn they're all expecting too much, too soon.

28 Oct 2020

IVI hosts virtual State Forum to promote partnership and equity in global health

The International Vaccine Institute (IVI) hosted a virtual State Forum today to advocate for multilateral cooperation through vaccine diplomacy.

13 Oct 2020

How might India's monsoon season impact COVID-19 ?

A new study, by two Goethe University Frankfurt researchers, published on the preprint server medRxiv* in September 2020 explores the relationship between the monsoon season, the chances of exposure to ultraviolet B (UVB) radiation, and the COVID-19 mortality.

29 Sep 2020

U.S. scientists to create coronavirus strain for human challenge trials

Now, a team of scientists in the United States plans to create a coronavirus strain that can be used for human challenge trials, a controversial type of study wherein health volunteers would be vaccinated and intentionally infected with the virus.

16 Aug 2020

Finland joins international organization dedicated to COVID-19 vaccines

The flag of Finland was raised at the International Vaccine Institute (IVI) Headquarters today during a ceremony welcoming the country's accession to IVI.

11 Aug 2020

Multiple, intertwined cell death systems to prevent the spread of 'intracellular' bacteria

Melbourne researchers have revealed the multiple, intertwined cell death systems that prevent the spread of the 'intracellular' bacterium Salmonella, an important cause of typhoid fever which kills more than 100,000 people annually.

30 Jul 2020

Deaths of Chinese children, adolescents from infectious diseases prior to COVID-19 found to be rare

Deaths of children and adolescents in China due to infectious diseases were becoming rare prior to the COVID-19 pandemic, according to a new study.

3 Apr 2020

A joint effort to confront the challenges of rising antimicrobial resistance in Asia

The International Vaccine Institute (IVI) and the Technical University of Denmark's (DTU) National Food Institute announced today a joint effort to strengthen external quality assurance programs for diagnostic laboratories in Asia to confront the challenges of rising antimicrobial resistance (AMR) in the region.

6 Mar 2020

Study identifies previously unknown toxic by-products potentially present in drinking water

Researchers at John Hopkins University have found that the most common method for disinfecting water can generate toxic by-products.

29 Jan 2020

LSTM to host a high-level symposium ahead of major vaccine conference in London

On Thursday 26 March, the Liverpool School of Tropical Medicine will bring together high-level representatives from organizations like the World Health Organization and key stakeholders in the private and public sectors along with scientists and doctors.

27 Jan 2020

Study links use of acid reflux drugs with poorer concentration, memory in breast cancer survivors

Acid reflux drugs that are sometimes recommended to ease stomach problems during cancer treatment may have an unintended side effect: impairment of breast cancer survivors' memory and concentration.

17 Jan 2020

Lymphopenia may hint a higher risk of future illness, death

Lymphopenia, which indicates lower levels of lymphocytes in the blood, has been tied to a higher risk of future illness and death, a new study found.

13 Jan 2020

Sida continues to support IVI’s mission to accelerate vaccine research

The International Vaccine Institute, a Seoul, Korea-based international organization, announced today that the Swedish International Cooperation Agency will continue to support IVI's mission to accelerate vaccine research and development for global health with a total contribution of SEK 50 million (approximately 5.24 million USD) over the next five years as part of a longstanding partnership between the Swedish government and IVI.

13 Jan 2020

UMSOM research shows even milder cases of diarrheal diseases can lead to child mortality

Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age.

9 Jan 2020

UMSOM researchers to test the safety, tolerability of prototype Shigella-ETEC vaccine

Each year, millions of people contract serious diarrheal illnesses typically from contaminated food and water. Among the biggest causes of diarrheal diseases are the bacteria Shigella and enterotoxigenic Escherichia coli, and researchers at the University of Maryland School of Medicine are testing a vaccine designed to offer protection against these serious pathogens.

10 Dec 2019

Typhoid conjugate vaccine proves its worth in the field

A new typhoid conjugate vaccine (TCV) that has been approved by the World Health Organization (WHO) Global Advisory Committee on Vaccine Safety has proved extremely effective in both young children and adults in a high-endemicity area for the first time. With almost 82% of recipients showing protection against typhoid, the vaccine promises to help control this deadly disease that claims up to 160,000 of its 11 million victims each year.

5 Dec 2019

Study shows link between inflammation and mental sluggishness

Scientists at the University of Birmingham in collaboration with the University of Amsterdam have uncovered a possible explanation for the mental sluggishness that often accompanies illness.

15 Nov 2019

New report highlights the plight of sanitation workers in the developing world

Millions of sanitation workers in the developing world are forced to work in conditions that endanger their health and lives, and violate their dignity and human rights, according to a report released today.

14 Nov 2019

Raw pet food a risk for humans and animals

The team wrote, “Feeding pets raw meat-based diets (RMBDs) has become increasingly popular but may constitute a risk due to the contamination with pathogenic and antimicrobial-resistant (AMR) bacteria.”

17 Oct 2019

UMSOM receives landmark contract from NIAID for influenza research

Kathleen Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine and Dean E. Albert Reece, MD, PhD, MBA, announced that CVD has been awarded a contract from the National Institute of Allergy and Infectious Diseases, with total funding up to more than $200 million over seven years if all contract options are exercised.

20 Sep 2019